Q1 2024 Holdings
Filed 2024-05-15 | 74 holdings | $1.8B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-08-14) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Natera Inc(NTRA) | COM | 632307104 | $141.8M | 1,550,280 | 7.9% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $120.5M | 2,793,987 | 6.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $114.0M | 754,032 | 6.3% |
| Aerovate Therapeutics Inc | COM | 008064107 | $111.1M | 3,758,686 | 6.2% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $85.9M | 651,299 | 4.8% |
| Spdr Ser Tr(XBI)Put | S&P BIOTECH | 78464A870 | $80.7M | 850,000 | 4.5% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $78.6M | 611,884 | 4.4% |
| Incyte Corp(INCY) | COM | 45337C102 | $75.6M | 1,327,178 | 4.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $58.8M | 149,300 | 3.3% |
| Intuitive Surgical Inc(ISRG) | COM | 46120E602 | $56.2M | 140,880 | 3.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $55.0M | 1,936,650 | 3.1% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $45.5M | 1,302,645 | 2.5% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $41.6M | 2,555,547 | 2.3% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $40.6M | 75,224 | 2.3% |
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $40.4M | 596,713 | 2.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $38.3M | 1,608,540 | 2.1% |
| Insulet Corp(PODD) | COM | 45784P101 | $37.7M | 220,203 | 2.1% |
| Y-mAbs Therapeutics Inc(YMABUSD) | COM | 984241109 | $35.7M | 2,194,278 | 2.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $34.3M | 781,596 | 1.9% |
| Celldex Therapeutics Inc(CLDX) | COM | 15117B202 | $33.7M | 801,777 | 1.9% |
| Inozyme Pharma Inc | COM | 45790W108 | $32.8M | 4,280,308 | 1.8% |
| Align Technology Inc(ALGN) | COM | 016255101 | $31.3M | 95,478 | 1.7% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $30.3M | 1,696,752 | 1.7% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $30.2M | 1,984,962 | 1.7% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $29.5M | 227,488 | 1.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $24.2M | 353,851 | 1.3% |
| Immatics NV(IMTX) | SHS | N44445109 | $22.7M | 2,163,646 | 1.3% |
| Silk Rd Med Inc | COM | 82710M100 | $21.8M | 1,189,024 | 1.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $16.1M | 2,400,771 | 0.9% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $15.8M | 229,481 | 0.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $15.4M | 103,036 | 0.9% |
| Immunome Inc(IMNM) | COM | 45257U108 | $14.7M | 594,396 | 0.8% |
| Pharvaris N V(PHVS) | COM | N69605108 | $13.5M | 584,672 | 0.8% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM | 56854Q200 | $12.7M | 1,401,053 | 0.7% |
| Savara Inc(SVRA) | COM | 805111101 | $11.7M | 2,347,261 | 0.7% |
| Shockwave Med Inc(SWAVUSD) | COM | 82489T104 | $11.4M | 35,000 | 0.6% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $10.7M | 501,940 | 0.6% |
| Roivant Sciences Ltd(ROIV) | SHS | G76279101 | $10.6M | 1,001,704 | 0.6% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $10.3M | 149,385 | 0.6% |
| Marinus Pharmaceuticals Inc(MRNS*)Put | COM | 56854Q200 | $9.0M | 1,000,000 | 0.5% |
| Marinus Pharmaceuticals Inc(MRNS*)Call | COM | 56854Q200 | $7.7M | 854,700 | 0.4% |
| PepGen Inc(PEPG) | COM | 713317105 | $7.4M | 503,624 | 0.4% |
| Cabaletta Bio Inc(CABA) | COM | 12674W109 | $7.3M | 429,746 | 0.4% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $7.2M | 141,162 | 0.4% |
| Achieve Life Sciences Inc(ACHV) | COM | 004468500 | $6.9M | 1,518,230 | 0.4% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $6.5M | 150,775 | 0.4% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $6.3M | 198,186 | 0.4% |
| Nextcure Inc | COM | 65343E108 | $6.0M | 2,671,856 | 0.3% |
| Avantor Inc(AVTR) | COM | 05352A100 | $5.9M | 232,446 | 0.3% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $5.1M | 19,029 | 0.3% |